Similarly, CIBERSORT estimates of immune cell infiltration showed that patients with high MyD88 expression had more cancer-suppressing immune cells, such as M1 macrophages, and fewer cancer-promoting immune cells, such as M2 macrophages (Fig. 5B). Here, MYD88 is linked to cancer.